Status:
UNKNOWN
Methadone Associated With Morphine for Cancer Pain
Lead Sponsor:
Federal University of São Paulo
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study was prospective, randomized. Patients with cancer pain were evaluated, one group receiving methadone with morphine and another group receiving morphine as the only opioid. Pain intensity, to...
Detailed Description
Opioids are the most important analgesics for the relief of cancer pain. In addition tolerance and hyperalgesia may ocurr as a consequence of treatment with these drugs. Medications for pain relief ma...
Eligibility Criteria
Inclusion
- Approved by the Ethics Committee
- signed the informed consent
- cancer pain
- starting the WHO thirth analgesic ladder,
Exclusion
- cognitive impairment
- psychiatric disease
- illicit drug user
- hypersensitivity to the study drugs
- pregnant
Key Trial Info
Start Date :
March 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03324815
Start Date
March 2 2017
End Date
August 30 2018
Last Update
October 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rioko K Sakata
São Paulo, Brazil